Author

D.W. Ludovici

Observed names: D. Ludovici, D. W. LUDOVICI, D. W. Ludovici, Don Ludovici

Observed institutions: Rutgers, The State University of New Jersey, Janssen (Belgium), Janssen Research & Development (United States)

OpenAlex ID: A5110096882

In Search of a Novel Anti-HIV Drug: Multidisciplinary Coordination in the Discovery of 4-[[4-[[4-[(1 E )-2-Cyanoethenyl]-2,6-dimethylphenyl]amino]-2- pyrimidinyl]amino]benzonitrile (R278474, Rilpivirine)

2004 · Paul A. J. Janssen, Paul J. Lewi, et al. · Journal of Medicinal Chemistry · 348

Small molecule inhibitors of methionine aminopeptidase type 2 (MetAP-2) fail to inhibit endothelial cell proliferation or formation of microvessels from rat aortic rings in vitro

2004 · Thomas Garrabrant, Robert Tuman, et al. · Angiogenesis · 47

2-Ethynylbenzenealkanamines. A new class of calcium entry blockers

1988 · J. R. Carson, H. R. Almond, et al. · Journal of Medicinal Chemistry · 27

430 Design and structure–activity relationships of highly potent and bioavailable imidazolinone FASN KR domain inhibitors

2014 · G. Bignan, R. Alexander, et al. · European Journal of Cancer

Evolution of anti-HIV drug candidates diaryltriazines (DATA) analogs

2001 · D.W. Ludovici, Robert W. Kavash, et al.

ChemInform Abstract: 2‐Ethynylbenzenealkanamines. A New Class of Calcium Entry Blockers.

1988 · J. R. CARSON, H. R. ALMOND, et al. · ChemInform

2-Ethynylbenzenealkanamines: a new class of calcium entry blockers with potential antihypertensive and antianginal properties

1986 · Brannan, John R. Carson, et al. · Fed. Proc., Fed. Am. Soc. Exp. Biol.; (United States)

Works count: 7

Citation count: 422

H-index: 3

I10-index: 3